June 16, 2014
CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation
CALIXAR, company specialized in the native isolation of integral membrane protein targets, announced today the issue of a new generation of compounds able to extract and stabilize complex pharmaceutical targets.